Financial

Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

VANCOUVER and MINNEAPOLIS, May 25, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that it has received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth […]

Hello Heart Completes $45M Investment to Fuel Growth and Expand Digital Heart Health

Series C financing was led by IVP and includes existing investors MENLO PARK, Calif.–(BUSINESS WIRE)–Hello Heart, the best-in-class heart health digital therapeutics solution, has completed a $45 million Series C led by IVP. IVP is a top later-stage partner for hypergrowth companies including Coinbase, Lyra Health, Slack, Snap, Twitter, and […]

Emboline Raises over $55 Million in Series D Funding for Pivotal FDA Clinical Study and Market Launch of the Emboliner™ Embolic Protection Catheter to Minimize Stroke Risk from TAVR

Financing led by Matrix Capital Management with significant investment from an undisclosed strategic investor — Eric Xiao of Matrix Capital Management to join the Emboline Board of Directors SANTA CRUZ, Calif., May 25, 2021 /PRNewswire/ — Emboline, Inc., a privately held medical device company focused on reducing stroke and other damage caused by embolic […]

Rapid Medical Announces Closing of $50m Series D Financing

Proceeds to Fund the Company’s Worldwide Commercial Expansion Series D fundraising led by MicroPort YOKNEAM, Israel–(BUSINESS WIRE)–Rapid Medical, a company focused on the development of responsive, adjustable neurovascular devices, announced today that it has completed an oversubscribed Series D financing of $50M. The proceeds will be used to support the […]

MCRA Expands its Cardiovascular Division, Hiring Fernando Aguel, Former Assistant Division Director, FDA Circulatory Support Devices

WASHINGTON, May 20, 2021 /PRNewswire/ — MCRA, LLC, a leading medical device and biologics advisory firm and clinical research organization (CRO) integrating US and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, and Quality Assurance, is pleased to announce the hiring of Fernando Aguel as Vice President, Heart Failure & Circulatory Support Regulatory Affairs. Fernando […]

Humacyte Appoints Dale Sander as Chief Financial Officer

Proven CFO with extensive financial leadership and commercialization experience, including multiple publicly listed life sciences companies DURHAM, N.C., May 19, 2021 (GLOBE NEWSWIRE) — Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the appointment of Dale Sander as Chief Financial […]

Xenter, Inc. Continues Rapid Expansion with Appointment of Scott Heuler, SVP of Global Sales and Marketing, and Gary Baldwin as CTO

–Xenter Continues Rapid Expansion to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health– SALT LAKE CITY–(BUSINESS WIRE)–On the heels of last week’s announcement of the closing of its $12M Series A offering, Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of Scott […]